N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome

Summary

We would study whether there is any measurable benefit of the administration of nebulized n-acetyl-cysteine to acute respiratory distress syndrome patients starting within 48 hours of intubation and mechanical ventilation.

Timeline

Start

2018-02-01

Primary completion

2021-01-30

Completion

2021-01-30

Drugs

Indications